Earlier this month we celebrated National Cancer Survivors Day and then learned that some 70% of breast cancer patients may be able to skip chemo - what a way to kick off June! The TAILORx trial, or more formally Trial Assigning Individualized Options for Treatment (Rx) trial, used a molecular test to examine tumors and assess 21 genes connected with breast cancer recurrence to determine the most appropriate post-operative treatment for women with hormone receptor (HR)-positi